Characterization of the APP SAA mouse model for use in preclinical testing of Alzheimer's disease therapeutics

Abstract

Background: The APP SAA mouse was developed to provide a model of Alzheimer's disease (AD) that is accessible for preclinical research without licensing restrictions, or artifacts due to transgenic overexpression (Xia et al, 2022).